Introduction: EsophyX is an endoluminal approach to the treatment of gastroesophageal reflux disease (GERD). We report one of the earliest and largest North American experiences with this device.
Methods: Prospective data were gathered on consecutive patients undergoing EsophyX fundoplication for a one-year period between September 2007 and 2008, during which time the procedure evolved to the current technique. Data are expressed as mean (SD), p
Session: Podium Presentation
Program Number: S032